quinazolines has been researched along with Orthomyxoviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, T; Han, SB; Jeong, EJ; Kim, H; Kim, M; Noh, K; Shin, JS | 1 |
| Compans, RW; Pollack, BP; Pulit-Penaloza, JA; Sapkota, B; Skountzou, I; Stein Esser, E | 1 |
2 other study(ies) available for quinazolines and Orthomyxoviridae Infections
| Article | Year |
|---|---|
The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.
Topics: Adjuvants, Immunologic; Adjuvants, Vaccine; Administration, Intranasal; Animals; Antibodies, Viral; Humans; Immunity, Mucosal; Influenza A virus; Influenza Vaccines; Influenza, Human; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Quinazolines; Toll-Like Receptor 7 | 2022 |
Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.
Topics: Administration, Topical; Animals; Chemokine CCL2; Cytokines; ErbB Receptors; Female; Immunity, Humoral; Influenza Vaccines; Lymph Nodes; Mice, Inbred BALB C; Orthomyxoviridae Infections; Protein Kinase Inhibitors; Quinazolines; Skin; Vaccination | 2015 |